If it’s already being used on the face then I guess that settles the dermatology/aesthetics question even more.
For reference look up “Avita medical Tehran” for an article from about 2015 or see my post from 2018. It has already been done successfully.
From the impatient to the patient.
- Forums
- ASX - By Stock
- AVH
- Listen to this
Listen to this, page-2
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.72 |
Change
0.090(3.42%) |
Mkt cap ! $186.5M |
Open | High | Low | Value | Volume |
$2.74 | $2.77 | $2.66 | $887.5K | 325.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 203 | $2.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.73 | 900 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 203 | 2.720 |
4 | 9889 | 2.710 |
5 | 38789 | 2.700 |
1 | 3000 | 2.690 |
2 | 32312 | 2.680 |
Price($) | Vol. | No. |
---|---|---|
2.730 | 900 | 1 |
2.740 | 2332 | 4 |
2.750 | 6162 | 5 |
2.760 | 8852 | 4 |
2.770 | 14694 | 3 |
Last trade - 14.14pm 15/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online